Table 3.
Description of SARS-CoV-2 positive children admitted to ICU.
| Patient number | Age | Underlying condition | Clinical features | Outcome |
|---|---|---|---|---|
| 1 | 22 days | None | Acute upper respiratory tract infection. Non-invasive respiratory support needed. No viral coinfection | Alive |
| 2 | 23 days | None | Acute upper respiratory tract infection. Non-invasive respiratory support and enteral nutrition support needed. No viral coinfection. | Alive |
| 3 | 1 month | None | Acute upper respiratory tract infection. Enteral nutrition support needed. No viral coinfection. | Alive |
| 4 | 1 month | None | Severe acute bronchiolitis. Non-invasive respiratory support needed. Coinfection with influenzavirus | Alive |
| 5 | 1 month | None | Gastrointestinal symptoms. Enteral nutrition support needed. No viral coinfection | Alive |
| 6 | 1 month | Preterm birth | Acute upper respiratory tract infection. Non-invasive respiratory support needed. Coinfection with Parainfluenzavirus 3 | Alive |
| 7 | 1 month | None | Severe acute bronchiolitis. Non-invasive respiratory support needed. Coinfection with RSV | Alive |
| 8 | 1 month | None | Severe acute bronchiolitis. Non-invasive respiratory support needed. Coinfection with RSV | Alive |
| 9 | 1 month | None | Severe acute bronchiolitis. Non-invasive respiratory support needed. Coinfection with RSV | Alive |
| 10 | 1 month | None | Gastrointestinal symptoms. Enteral nutrition support needed. No viral coinfection | Alive |
| 11 | 2 months | None | Severe pneumonia with evolution to acute respiratory distress syndrome. No viral coinfection. Bacterial pulmonary co-infection with E. coli K1 | Death |
| 12 | 2 months | None | Severe acute bronchiolitis. Non-invasive respiratory support needed. Coinfection with RSV | Alive |
| 13 | 2 months | None | Severe pneumonia following aspiration from dysphagia. Non-invasive respiratory support needed. No viral coinfection. | Alive |
| 14 | 4 months | polycystic kidney disease | Moderate pneumonia. Non-invasive respiratory support needed. Corticosteroid therapy. No viral coinfection. | Alive |
| 15 | 3.2 years | Asthma | Severe pneumonia. Coinfection with RSV and HRV/EV | Alive |
| 16 | 3.8 years | sickle cell disease | Acute chest syndrome and acute hemolytic anemia. No viral coinfection | Alive |
| 17 | 8.4 years | Pansinusitis complicated by cerebral empyema | Postoperative ICU admission. Not related to COVID-19 | Alive |